When should polymyxin B-immobilized polystyrene column be introduced to improve COVID-19 prognosis?
Ther Apher Dial
.
2022 Jun;26(3):550-551.
doi: 10.1111/1744-9987.13825.
Epub 2022 Mar 10.
Authors
Daisuke Katagiri
1
,
Shinyu Izumi
2
,
Hideki Takano
1
Affiliations
1
Department of Nephrology, National Center for Global Health and Medicine, Tokyo, Japan.
2
Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan.
PMID:
35247232
PMCID:
PMC9111317
DOI:
10.1111/1744-9987.13825
No abstract available
Publication types
Letter
MeSH terms
Anti-Bacterial Agents / therapeutic use
COVID-19*
Hemoperfusion*
Humans
Polymyxin B
Polystyrenes
Prognosis
Shock, Septic* / therapy
Substances
Anti-Bacterial Agents
Polystyrenes
Polymyxin B